Report Detail

Medical Devices & Consumables Global Immortalized Human Cells Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4661740
  • |
  • 29 June, 2026
  • |
  • Global
  • |
  • 134 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Immortalized Human Cells market size was valued at US$ 1623 million in 2025 and is forecast to a readjusted size of US$ 3454 million by 2032 with a CAGR of 11.5% during review period.
The global volume of technical services related to immortalized human cells reached approximately 3.72 million projects in 2024, with an average customer price of $403.15 per project. Immortalized human cells are human cell lines with unlimited proliferative capacity obtained through genetic engineering techniques. Related technical services include cell line establishment, gene editing, functional validation, drug screening, and customized culture. These services provide crucial technology platforms and solutions for drug development, disease modeling, and biomedical research, significantly enhancing research efficiency and reliability.
The technical service market for immortalized human cells is currently in a critical phase of rapid professionalization and standardization. The market's current state is characterized by growing demand for regulatory-compliant standardized cell line establishment, complex gene editing, and high-quality functional validation services, driven by the needs of precision medicine and personalized therapies. Professional CRO companies and large biotechnology firms dominate the market by establishing standardized technology platforms and quality systems. The development trend is clearly directed towards higher throughput and more precise technical services, including the integration of innovative services such as automated screening platforms, multi-omics analysis integration, and AI-assisted cell phenotype analysis. The prevailing market view is that future competition will extend beyond basic technical services to focus more on the capability to provide integrated solutions, data quality and depth of analytical value, and the completeness of technical systems meeting stringent regulatory requirements. Meanwhile, balancing service standardization with personalized needs will become a significant challenge for enterprises.
This report is a detailed and comprehensive analysis for global Immortalized Human Cells market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Immortalized Human Cells market size and forecasts, in consumption value ($ Million), 2021-2032
Global Immortalized Human Cells market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Immortalized Human Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Immortalized Human Cells market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immortalized Human Cells
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immortalized Human Cells market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ispecimen, ABO Bio, AnaBios, Biomedica Cro, Bioivt, Iprocess, Crown Bioscience, Biomex, PrecisionMed, Cureline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Immortalized Human Cells market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ready-to-use
Customized
Market segment by Source
Liver-Derived
Kidney-Derived
Nervous System-Derived
Other
Market segment by Identity
Identified Samples
Anonymized Samples
Market segment by Application
Medical Research
Vaccine Development
Gene Therapy
Other
Market segment by players, this report covers
Ispecimen
ABO Bio
AnaBios
Biomedica Cro
Bioivt
Iprocess
Crown Bioscience
Biomex
PrecisionMed
Cureline
DX Biosamples
Audubon
Precision for Medicine
Discovery Life Sciences
ProteoGenex
CGT Global
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immortalized Human Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immortalized Human Cells, with revenue, gross margin, and global market share of Immortalized Human Cells from 2021 to 2026.
Chapter 3, the Immortalized Human Cells competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Immortalized Human Cells market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immortalized Human Cells.
Chapter 13, to describe Immortalized Human Cells research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Immortalized Human Cells by Type
    • 1.3.1 Overview: Global Immortalized Human Cells Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Immortalized Human Cells Consumption Value Market Share by Type in 2025
    • 1.3.3 Ready-to-use
    • 1.3.4 Customized
  • 1.4 Classification of Immortalized Human Cells by Source
    • 1.4.1 Overview: Global Immortalized Human Cells Market Size by Source: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Immortalized Human Cells Consumption Value Market Share by Source in 2025
    • 1.4.3 Liver-Derived
    • 1.4.4 Kidney-Derived
    • 1.4.5 Nervous System-Derived
    • 1.4.6 Other
  • 1.5 Classification of Immortalized Human Cells by Identity
    • 1.5.1 Overview: Global Immortalized Human Cells Market Size by Identity: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Immortalized Human Cells Consumption Value Market Share by Identity in 2025
    • 1.5.3 Identified Samples
    • 1.5.4 Anonymized Samples
  • 1.6 Global Immortalized Human Cells Market by Application
    • 1.6.1 Overview: Global Immortalized Human Cells Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Medical Research
    • 1.6.3 Vaccine Development
    • 1.6.4 Gene Therapy
    • 1.6.5 Other
  • 1.7 Global Immortalized Human Cells Market Size & Forecast
  • 1.8 Global Immortalized Human Cells Market Size and Forecast by Region
    • 1.8.1 Global Immortalized Human Cells Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Immortalized Human Cells Market Size by Region, (2021-2032)
    • 1.8.3 North America Immortalized Human Cells Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Immortalized Human Cells Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Immortalized Human Cells Market Size and Prospect (2021-2032)
    • 1.8.6 South America Immortalized Human Cells Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Immortalized Human Cells Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Ispecimen
    • 2.1.1 Ispecimen Details
    • 2.1.2 Ispecimen Major Business
    • 2.1.3 Ispecimen Immortalized Human Cells Product and Solutions
    • 2.1.4 Ispecimen Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Ispecimen Recent Developments and Future Plans
  • 2.2 ABO Bio
    • 2.2.1 ABO Bio Details
    • 2.2.2 ABO Bio Major Business
    • 2.2.3 ABO Bio Immortalized Human Cells Product and Solutions
    • 2.2.4 ABO Bio Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ABO Bio Recent Developments and Future Plans
  • 2.3 AnaBios
    • 2.3.1 AnaBios Details
    • 2.3.2 AnaBios Major Business
    • 2.3.3 AnaBios Immortalized Human Cells Product and Solutions
    • 2.3.4 AnaBios Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 AnaBios Recent Developments and Future Plans
  • 2.4 Biomedica Cro
    • 2.4.1 Biomedica Cro Details
    • 2.4.2 Biomedica Cro Major Business
    • 2.4.3 Biomedica Cro Immortalized Human Cells Product and Solutions
    • 2.4.4 Biomedica Cro Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Biomedica Cro Recent Developments and Future Plans
  • 2.5 Bioivt
    • 2.5.1 Bioivt Details
    • 2.5.2 Bioivt Major Business
    • 2.5.3 Bioivt Immortalized Human Cells Product and Solutions
    • 2.5.4 Bioivt Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Bioivt Recent Developments and Future Plans
  • 2.6 Iprocess
    • 2.6.1 Iprocess Details
    • 2.6.2 Iprocess Major Business
    • 2.6.3 Iprocess Immortalized Human Cells Product and Solutions
    • 2.6.4 Iprocess Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Iprocess Recent Developments and Future Plans
  • 2.7 Crown Bioscience
    • 2.7.1 Crown Bioscience Details
    • 2.7.2 Crown Bioscience Major Business
    • 2.7.3 Crown Bioscience Immortalized Human Cells Product and Solutions
    • 2.7.4 Crown Bioscience Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Crown Bioscience Recent Developments and Future Plans
  • 2.8 Biomex
    • 2.8.1 Biomex Details
    • 2.8.2 Biomex Major Business
    • 2.8.3 Biomex Immortalized Human Cells Product and Solutions
    • 2.8.4 Biomex Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Biomex Recent Developments and Future Plans
  • 2.9 PrecisionMed
    • 2.9.1 PrecisionMed Details
    • 2.9.2 PrecisionMed Major Business
    • 2.9.3 PrecisionMed Immortalized Human Cells Product and Solutions
    • 2.9.4 PrecisionMed Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 PrecisionMed Recent Developments and Future Plans
  • 2.10 Cureline
    • 2.10.1 Cureline Details
    • 2.10.2 Cureline Major Business
    • 2.10.3 Cureline Immortalized Human Cells Product and Solutions
    • 2.10.4 Cureline Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Cureline Recent Developments and Future Plans
  • 2.11 DX Biosamples
    • 2.11.1 DX Biosamples Details
    • 2.11.2 DX Biosamples Major Business
    • 2.11.3 DX Biosamples Immortalized Human Cells Product and Solutions
    • 2.11.4 DX Biosamples Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 DX Biosamples Recent Developments and Future Plans
  • 2.12 Audubon
    • 2.12.1 Audubon Details
    • 2.12.2 Audubon Major Business
    • 2.12.3 Audubon Immortalized Human Cells Product and Solutions
    • 2.12.4 Audubon Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Audubon Recent Developments and Future Plans
  • 2.13 Precision for Medicine
    • 2.13.1 Precision for Medicine Details
    • 2.13.2 Precision for Medicine Major Business
    • 2.13.3 Precision for Medicine Immortalized Human Cells Product and Solutions
    • 2.13.4 Precision for Medicine Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Precision for Medicine Recent Developments and Future Plans
  • 2.14 Discovery Life Sciences
    • 2.14.1 Discovery Life Sciences Details
    • 2.14.2 Discovery Life Sciences Major Business
    • 2.14.3 Discovery Life Sciences Immortalized Human Cells Product and Solutions
    • 2.14.4 Discovery Life Sciences Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Discovery Life Sciences Recent Developments and Future Plans
  • 2.15 ProteoGenex
    • 2.15.1 ProteoGenex Details
    • 2.15.2 ProteoGenex Major Business
    • 2.15.3 ProteoGenex Immortalized Human Cells Product and Solutions
    • 2.15.4 ProteoGenex Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 ProteoGenex Recent Developments and Future Plans
  • 2.16 CGT Global
    • 2.16.1 CGT Global Details
    • 2.16.2 CGT Global Major Business
    • 2.16.3 CGT Global Immortalized Human Cells Product and Solutions
    • 2.16.4 CGT Global Immortalized Human Cells Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 CGT Global Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Immortalized Human Cells Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Immortalized Human Cells by Company Revenue
    • 3.2.2 Top 3 Immortalized Human Cells Players Market Share in 2025
    • 3.2.3 Top 6 Immortalized Human Cells Players Market Share in 2025
  • 3.3 Immortalized Human Cells Market: Overall Company Footprint Analysis
    • 3.3.1 Immortalized Human Cells Market: Region Footprint
    • 3.3.2 Immortalized Human Cells Market: Company Product Type Footprint
    • 3.3.3 Immortalized Human Cells Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Immortalized Human Cells Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Immortalized Human Cells Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Immortalized Human Cells Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Immortalized Human Cells Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Immortalized Human Cells Consumption Value by Type (2021-2032)
  • 6.2 North America Immortalized Human Cells Market Size by Application (2021-2032)
  • 6.3 North America Immortalized Human Cells Market Size by Country
    • 6.3.1 North America Immortalized Human Cells Consumption Value by Country (2021-2032)
    • 6.3.2 United States Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Immortalized Human Cells Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Immortalized Human Cells Consumption Value by Type (2021-2032)
  • 7.2 Europe Immortalized Human Cells Consumption Value by Application (2021-2032)
  • 7.3 Europe Immortalized Human Cells Market Size by Country
    • 7.3.1 Europe Immortalized Human Cells Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 7.3.3 France Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Immortalized Human Cells Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Immortalized Human Cells Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Immortalized Human Cells Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Immortalized Human Cells Market Size by Region
    • 8.3.1 Asia-Pacific Immortalized Human Cells Consumption Value by Region (2021-2032)
    • 8.3.2 China Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 8.3.5 India Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Immortalized Human Cells Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Immortalized Human Cells Consumption Value by Type (2021-2032)
  • 9.2 South America Immortalized Human Cells Consumption Value by Application (2021-2032)
  • 9.3 South America Immortalized Human Cells Market Size by Country
    • 9.3.1 South America Immortalized Human Cells Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Immortalized Human Cells Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Immortalized Human Cells Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Immortalized Human Cells Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Immortalized Human Cells Market Size by Country
    • 10.3.1 Middle East & Africa Immortalized Human Cells Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Immortalized Human Cells Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Immortalized Human Cells Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Immortalized Human Cells Market Drivers
  • 11.2 Immortalized Human Cells Market Restraints
  • 11.3 Immortalized Human Cells Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Immortalized Human Cells Industry Chain
  • 12.2 Immortalized Human Cells Upstream Analysis
  • 12.3 Immortalized Human Cells Midstream Analysis
  • 12.4 Immortalized Human Cells Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Immortalized Human Cells. Industry analysis & Market Report on Immortalized Human Cells is a syndicated market report, published as Global Immortalized Human Cells Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Immortalized Human Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report